Scenario 2.1*** Number of second-phase subjects: 300 cases 300 controls | Scenario 2.2 Number of second-phase subjects: 400 cases 200 controls | Scenario 2.3 Number of second- phase subjects: 200 cases 400 controls | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
True OR†† | OR* | SD* | Ef** | OR* | SD* | Ef** | OR* | SD* | Ef** | |
Individual-level information on all subjects † | 1.50 | 1.50 | 0.12 | 100 | 1.49 | 0.12 | 100 | 1.50 | 0.12 | 100 |
3.00 | 3.00 | 0.11 | 100 | 3.02 | 0.12 | 100 | 3.02 | 0.12 | 100 | |
Method 3‡ | 1.50 | 1.50 | 0.22 | 29 | 1.49 | 0.23 | 27 | 1.52 | 0.22 | 30 |
3.00 | 2.98 | 0.21 | 29 | 2.97 | 0.21 | 30 | 3.05 | 0.20 | 35 | |
Method 4‡ | 1.50 | 1.50 | 0.20 | 37 | 1.51 | 0.18 | 46 | 1.51 | 0.21 | 34 |
3.00 | 3.01 | 0.17 | 44 | 3.02 | 0.16 | 51 | 3.04 | 0.17 | 46 |